Nectar Lifesciences Limited — Others, 24-07-2025: Copy of Newspaper Publication

Nectar Lifesciences Ltd. has released a corrigendum to its upcoming Extraordinary General Meeting (EGM) notice, scheduled for August 4. The company's Board has clarified the proposed use of sale proceeds from a transaction. The updated explanatory statement specifies that funds allocated for "rewarding shareholders" will now explicitly include options such as special dividends and/or a buyback of equity shares, or a mix of both. This offers investors more clarity on potential capital distribution plans.